Cardlytics, Inc. CDLX

Q2 FY2026 · ended Jun 30, 2026 · Revenue $36.88M, -36.5% YoY · Filed Aug 5, 2026

Cardlytics, Inc. (CDLX) files with the SEC under industry code 7370, Services-Computer Programming, Data Processing, Etc. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $36.9 million and a net loss of $14.9 million. Free cash flow was -$8.6 million. As of Jun 30, 2026 it held $28.0 million in cash and investments and $189.9 million in total debt.

Revenue
$36.88M
-36.5% vs year-ago quarter
Net income
$-14.88M
-60.2% vs year-ago quarter
Operating cash flow
$-8.60M
-801.8% vs year-ago quarter
Free cash flow
$-8.60M
-1052.3% vs year-ago quarter
EPS
$-0.15
+50.3% vs year-ago quarter
Dividend per share
None
Shares outstanding
5.89M
-88.9% vs year-ago quarter
Net cash
$-161.85M
Q2 FY2026
Operating margin
-56.1%
TTM

Company profile

Industry
Services-Computer Programming, Data Processing, Etc. (SIC 7370)
Listed as
CDLX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Atlanta, GA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1666071

Other Services-Computer Programming, Data Processing, Etc. companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$36.9M
$34.3M
$50.9M
$47.0M
$58.0M
Operating income
-$5.4M
-$8.3M
-$6.1M
-$68.9M
-$9.6M
Net income
-$14.9M
-$4.5M
-$8.2M
-$72.7M
-$9.3M
Diluted EPS
—
—
-$0.15
-$1.36
-$0.18
Operating cash flow
-$8.6M
-$5.6M
$13.0M
$1.8M
$1.2M
Free cash flow
-$8.6M
-$5.7M
$13.0M
$1.7M
$903,000
Total assets
$234.8M
$263.9M
$285.6M
$292.8M
$361.1M
Total liabilities
$250.8M
$267.9M
$292.1M
$297.5M
$302.4M
Stockholders' equity
-$16.0M
-$4.0M
-$6.5M
-$4.7M
$58.7M
Cash and investments
$28.0M
$59.8M
$48.7M
$44.0M
$46.7M
Total debt
$189.9M
$210.0M
$215.3M
$267.5M
$266.4M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Material agreement
Sep 11, 2026 Sep 4, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Listing notice, Change to shareholder rights
Jun 3, 2026 Jun 3, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.